Thus, CD19.CAR NK cells co-expressing IL15/IL15Rα exhibited superior antitumor activity against lymphoma cells in vivo compared to CAR construct co-expressing soluble IL-15 or no cytokines. Here, IL15RA is linked to lymphoma.